Expansion of clinical genetic testing since the completion of the human genome project
Bastarache, L.; Tinker, R. J.; Schuler, B.; Richter, L.; Phillips, J.; Stead, W.; Hooker, G.; Peterson, J. F.; Ruderfer, D. M.
Show abstract
The sequencing of the first human genome led to expectations of the widespread use of genetics in medicine. However, assessing the true impact of genetic testing on clinical practice is challenging due to the lack of integration in the electronic health record (EHR). We extracted clinical genetic tests from the EHRs of over 1.8 million patients seen at Vanderbilt University Medical Center from 2002 to 2022, using both automated and manual methods. Using these data, we quantified the extent of clinical genetic testing in healthcare and described how testing patterns have changed over time, including utilization rate, test comprehensiveness, diagnoses made, and the number of variants of uncertain significance (VUS) returned. We also assessed genetic testing rates across medical specialties and introduce a measure - the genetic attributed fraction (GAF) - to compute the proportion of observed phenotypes attributable to a genetic diagnosis. We identified 104,392 tests, 32% of which were only reported in unstructured text, and 19,032 molecularly confirmed diagnoses or risk factors. The proportion of patients genetic testing recorded in their EHRs from 1.0% in 2002 to 6.1% in 2022, and testing became more comprehensive with the growing use of multigene panels. This corresponded with a substantial increase in the variety of diseases diagnosed with genetic testing, from 51 unique diseases in 2002 to 509 in 2022, alongside a growing number of VUS. The phenome-wide GAF for 6,505,620 diagnoses made in 2022 was 0.46%, with 74 phenotypes having a GAF greater than 5%, including pancreatic insufficiency (67%), chorea (64%), atrial septal defect (24%), Microcephaly (17%), paraganglioma (17%), and ovarian cancer (6.8%). Our study provides a comprehensive quantification of the increasing role of genetic testing at a major academic medical institution. These results demonstrate the now pervasive use of genetic testing across diverse medical contexts and its growing utility in explaining observed medical phenome.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- A Framework for Automated Gene Selection in Genomic Screening 95%
- IGenomic answers for children: Dynamic analyses of >1000 pediatric rare disease genomes 95%
- The Importance of Automation in Genetic Diagnosis: Lessons from Analyzing an Inherited Retinal Degeneration Cohort with the Mendelian Analysis Toolkit (MATK) 94%
Similar papers in this journal
- Returning Actionable Genomic Results in a Research Biobank: Analytic Validity, Clinical Implementation and Resource Utilization 96%
- Extracting and calibrating evidence of variant pathogenicity from population biobank data 95%
- Identification of actionable genetic variants in 4,198 Scottish volunteers from the Viking Genes research cohort and implementation of return of results 93%
Similar papers in this journal
- A Pooled Electronic Consultation Program to Improve Access to Genetics Specialists 92%
- Combining rare and common genetic variants improves population risk stratification for breast cancer 92%
- Genetic Diagnosis of Facioscapulohumeral Muscular Dystrophy Type 1 Using Rare Variant Linkage Analysis and Long Read Genome Sequencing 91%
Similar papers in this journal
- Long-read genome sequencing for the diagnosis of neurodevelopmental disorders 93%
- Whole Genome Sequencing for the Diagnosis of Rare Disorders 92%
- Identification and validation of novel candidate risk genes in endocytic vesicular trafficking associated with esophageal atresia and tracheoesophageal fistulas 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.